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Purpose/Objective: Aim of the COBRA project is to create a 
consortium for SDC. The long term aim is building a Decision 
Support System (DSS) to allow treatment individualisation 
and perspective validation of these prediction models. 
Materials and Methods: H&N GEC-ESTRO Working Group 
(H&N G-E WG) participated in the project defining the 
consortium agreement, the ontology (data-set) and peer-
reviewing the general 'umbrella' protocol. The repository was 
realized on a SQL platform with an authorized web-based 
access of the centres. 
Results: The project was approved by the H&N G-E WG in 
December 2012. Eleven centers (10 European and 1 Asian) 
from 6 countries signed the agreement. Then the consortium 
approved the ontology. We identified 3 levels for the data 
set: Registry (epidemiology analysis), Procedures (prediction 
models and DSS) and Research (radiomics). The consortium 
decided to divide data sharing in 2 phases: only data 
belonging to the 1st level will be stored in the 1st phase, 
while in the 2nd phase the data from the other levels. The 
COBRA-Storage System (C-SS) architecture was defined on the 
ontology basis as well on the Ethic Committee (EC) protocols. 
After some comments by an Italian EC, the C-SS was updated 
in order to improve privacy standards. The C-SS is not time-
consuming, in fact due to the use of 'brokers' it can take the 
data directly from the centres storage systems by connecting 
with SQL, Access, File Maker Pro or Excel. The system is also 
structured to perform automatic archiving directly from the 
TPS or After loading machine. We are currently in discussion 
with several companies to offer this connection. The 
architecture is based on the concept of 'on-purpose data 
projection'. It means, that a temporary, 'virtual' repository is 
created 'ad hoc' each time and a new iteration is needed for 
research purposes. The C-SS architecture is privacy 
protecting, because it will never project data that could 
identify the individual patient. At the same time, whenever a 
new iteration of a model is needed, a fresh projection is 
newly produced on which the next iteration is calculated. 
This C-SS can also benefit from the so called 'distributed 
learning' approaches, in which data never leave the collecting 
institution, while learning algorithms and proposed predictive 
models travel instead, if some consortium members choose 
not to distribute their data. 
Conclusions: Setting up a consortium appears to be a useful 
tool toward the creation of a multi-system data sharing 
architecture. The C-SS seems to be well accepted by all 
involved parties, primarily because it does not change the 
center storing technologies, procedures and habits. The 
upload of the data is planned to start in 2015 and we expect 
to begin creating predictive models as soon as the data 
collection phase is finalized  
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Purpose/Objective: There is a choice of Co-60 or Ir-192 for 
HDR Brachytherapy and recent research has suggested other 
alternative radionuclides, Co-57 and Gd-153, could be used. 
This study demonstrates the differences between these 4 
radionuclides: physically, dosimetrically and economically.  
Materials and Methods: A literature review looking at all 4 
radionuclides was performed: physical size, specific activity, 
half- life, energy and shielding requirements were compared. 
Clinically patient follow up and local planning studies 
involving 20 patients for gynaecological HDR patients were 
examined for Co-60 and Ir-192, including typical treatment 
duration, prescription point and OAR patient dosimetry. The 
monetary cost of choosing Co-60 over Ir-192 was analysed 
over a 10 year HDR equipment life. 
Results: Gd-153 while having a sufficient half-life (242 days) 
for HDR has insufficient mean photon energy at 60.9keV and 
would be more suitable for PDR or intermediate LDR. Co-57 
has a half-life of 272 days, approximately 3.5 times longer 
than Ir-192 and has lower energy gamma emissions 123keV 
without electron contamination hence it requires less source 
shielding than Ir-192 and Co-60. Its radial dose function is 
greater and more uniform than that of Ir-192 but very similar 
to Co-60 therefore producing a more uniform dose. Ir-192 and 
Co-60 are well established as the commercially available HDR 
sources, while Co-57 is not commercially available and 
requires an alpha or proton beam for production. Co-60 and 
Ir-192 have very similar physical dimensions and our planning 
studies have demonstrated small differences between the 
two radionuclides: 2.4% increase in HR-CTV (p<0.01) and 3.3% 
increase in D2cc rectum (p<0.01) when using Co-60 compared 
to Ir-192, when prescribed to ICRU Point A and with 
consistent loading patterns, these small differences may 
indeed be swamped by other larger uncertainties in 
brachytherapy. Figure 1 demonstrates the treatment duration 
with Co-60 is no longer than for an Ir-192 source for a typical 
treatment up to 4 years (typical source lifetime). The 
greatest difference is seen in the nominal costs for the 
commercially available sources and the additional physics 
support required for source changes. Co-60 is €325,000, 
€100,000 cheaper than Ir-192 over the 10 year lifetime of the 
HDR equipment. 40% additional physics support is required 
for Ir-192 source changes. 
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Figure 1 Indicative treatment time comparisons 
 
Conclusions: Co-57 is a viable option for future development 
as a HDR radionuclide while Gd-153 will have limited uses for 
LDR or PDR. Of the commercially available sources little 
differences are observed between Co-60 and Ir-192 physically 
and clinically. The economic benefit of Co-60 is the greatest 
difference but other factors influence the choice of HDR 
equipment over and above the costs for most centres. 
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Purpose/Objective: Brachytherapy of intraocular tumors 
with 125I eye plaques has become a successful treatment 
modality and a viable alternative to enucleation. Plaque 
Simulator (PS) is an eye plaque treatment planning system 
(TPS) that uses TG-43 dosimetry. We aimed to verify the 
performance of the PS routinely used to plan patients having 
intraocular tumors. 
Materials and Methods: Relative dose distributions, including 
central axis depth dose and off axis dose profiles of 
Collaborative Ocular Melanoma Study (COMS) plaques with 
14, 16, 18 and 20 mm in diameter, loaded with model I25.S16 
seeds were measured using 1x1x1 mm3 Thermo Luminesans 
Dosimetry (TLD) cubes and computed using MCNP5 Monte 
Carlo code and Plaque Simulator (PS) TPS. Measurements and 
calculations were compared by normalizing 5 mm distance at 
the central axis of the plaque i.e COMS point. 
Results: For the central axis depth doses, the agreement 
between the measured and calculated dose distributions was 
within 13%, whereas deviations up to 22% were observed in 
single points far off-axis. For central axis dose distribution, 
the max difference among the PS, TLD and MCNP5 results was 
seen at 2 mm from the plaque center for all plaque sizes. For 
off axis dose distribution the maximum dose difference 
among the PS, TLD and MCNP5 results were seen at ± 12 mm 
from the central axis, periphery of the plaque. 
Conclusions: The Bebig Plaque Simulator is a reliable TPS for 
calculating relative dose distributions around realistic 
multiple 125I seed configurations if one understands its 
limitations at the first few milimeters around the plaque 
center and far off axis points. 
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Purpose/Objective: Purpose of this study was to verify the 
spatial dose distribution around a single iridium source using 
dosimetric films and compare the designated distribution 
with data generated by the treatment planning system (TPS). 
The secondary goal was to determine whether such 
measurements may be used to commission model based dose 
calculation algorithms (MBDCA). 
Materials and Methods: To determine the spatial distribution 
dose around the radioactive source radiochromic films MD-55 
were irradiated. Films during irradiation procedure were 
placed at different depths in the phantom and in the 
opposite orientation to the long axis of the source. Measured 
dose distribution has been checked and compared with the 
calculated spatial distribution of dose generated in the 
treatment planning system. The dose calculation has been 
performed according to the TG43 report. To compare two 
images presenting absorbed dose (measured and planned) 
analysis gamma factor has been used. 
Results: Comparison of the measured doses distribution and 
the corresponding dosegrids from TPS has showed that dose 
distribution around source may be measured using 
radiochromic films in certain dose range. The few areas of 
the images showed deviations from the acceptance criteria, 
mainly because of defects of films. 
 
Conclusions: The best matching of the measured and 
